⌘K

Login Start Free

Home/Filings/4/0001855763-22-000001

4//SEC Filing

Baxter Nicholas W 4

Accession 0001855763-22-000001

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 5:18 PM ET

Size

9.4 KB

Accession

0001855763-22-000001

Insider Transaction Report

Form 4

Period: 2022-03-08

Lexaria Bioscience Corp.LEXX

Baxter Nicholas W

Director

Transactions

Award
Stock Options
2022-03-08+3,400→ 11,800 total
Exercise: $3.39From: 2022-03-08Exp: 2027-03-08→ Common Shares (3,400 underlying)

Holdings

Stock Options
Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying)
6,500
common shares
11,000
Stock Options
Exercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (1,900 underlying)
8,400
Stock Options
Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (1,500 underlying)
1,500

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001312326

Filing Metadata

Form type: 4
Filed: Mar 7, 7:00 PM ET
Accepted: Mar 8, 5:18 PM ET
Size: 9.4 KB

View on SEC.gov